Literature DB >> 6323683

Effects of the leukotrienes on the vasculature and blood pressure of different species.

B A Berkowitz, B Zabko-Potapovich, R Valocik, J G Gleason.   

Abstract

We have examined in these studies the contractile activity of leukotrienes (LTs) C4, D4 and E4 on vascular ring segments obtained from several species and demonstrated that the distal segment of the guinea-pig pulmonary artery is a useful and convenient preparation for the study of LT vascular pharmacology. In vitro, LTs had no effect on aortic rings from rats, rabbits or guinea pigs. In contrast, LTs produced significant contraction of the distal portion of the pulmonary artery of the guinea pig. The rank of the contractile effects of LT was LTD4 = LTC4, greater than LTE4, with ED40 (molar) values of 6.1 X 10(-9), 1 X 10(-8) and 1.4 X 10(-6), respectively. Norepinephrine, serotonin and histamine were at least 50- to 100-fold less potent. Partial tolerance developed to the contractile action of LT in vitro. Vascular contraction produced by LTD4 was antagonized by a selective LT antagonist. No evidence for a relaxant action of LT was obtained as LTD4 and LTC4 failed to relax rabbit aorta or guinea-pig pulmonary arterial rings. The effects of LTD4 on hemodynamics in vivo were studied in anesthetized guinea pigs. LTD4 (0.1-10 micrograms/kg) significantly decreased cardiac output but increased pulmonary vascular resistance. To assess the activity of LTs in another species, the in vitro contractile response of monkey pulmonary artery was determined. LTD4 was also a potent contractile agent in this species with significant contraction obtained at 1 X 10(-9) M.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323683

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Mechanical stretch reveals different components of endothelial-mediated vascular tone in rat aortic strips.

Authors:  S Franchi-Micheli; P Failli; L Mazzetti; D Bani; M Ciuffi; L Zilletti
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.

Authors:  Laurence Walch; Xavier Norel; Magnus Bäck; Jean-Pierre Gascard; Sven-Erik Dahlén; Charles Brink
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

3.  Effects of bradykinin and leukotrienes B4 and D4 on the bovine bronchial artery in vitro: role of the endothelium.

Authors:  W R Tracey; P Eyre
Journal:  Agents Actions       Date:  1988-08

4.  Antagonism of leukotriene receptors and administration of a 5-lipoxygenase inhibitor do not affect hypoxic vasoconstriction.

Authors:  H M Thomas; M S Sourour; D Lopez; S H Foster
Journal:  Lung       Date:  1989       Impact factor: 2.584

5.  Expression of 5-lipoxygenase in pulmonary artery endothelial cells.

Authors:  Ying-Yi Zhang; Jennifer L Walker; Annong Huang; John F Keaney; Clary B Clish; Charles N Serhan; Joseph Loscalzo
Journal:  Biochem J       Date:  2002-01-15       Impact factor: 3.857

6.  The role of blood vessels in the bioconversion of leukotrienes in the pig.

Authors:  S A Galton; P J Piper
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

7.  Effects of leukotrienes C4 and D4 on human isolated saphenous veins.

Authors:  S P Allen; A H Chester; P J Piper; A P Sampson; E S Akl; M H Yacoub
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

8.  Leukotriene receptors on human pulmonary vascular endothelium.

Authors:  J L Ortiz; I Gorenne; J Cortijo; A Seller; C Labat; B Sarria; T S Abram; P J Gardiner; E Morcillo; C Brink
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

Review 9.  Cardiovascular consequences when nitric oxide and lipid signaling converge.

Authors:  Volker Rudolph; Bruce A Freeman
Journal:  Circ Res       Date:  2009-09-11       Impact factor: 17.367

10.  Contraction of guinea pig inferior vena cava by eicosanoids.

Authors:  L E Rinkema; C R Roman; E L VanAlstyne; S M Spaethe; J H Fleisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.